Class
- Triptan
Frovatriptan
Commonly Prescribed for
(FDA approved in bold)
- Migraine
- Menstrual migraine
Frovatriptan
How the Drug Works
- Selective 5-HT1 receptor agonist, working predominantly at the B and D receptor subtypes. Effectiveness may be due to blocking the transmission of pain signals from the trigeminal nerve to the trigeminal nucleus caudalis and preventing release of inflammatory neuropeptides rather than just causing vasoconstriction
Frovatriptan
How Long Until It Works
- 2 hours or less
Frovatriptan
If It Works
- Continue to take as needed. Patients taking acute treatment more than 2 days/week are at risk for medication-overuse headache, especially if they have migraine
Frovatriptan
If It Doesn’t Work
- Treat early in the attack – triptans are less likely to work after the development of cutaneous allodynia, a marker of central sensitization
- For patients with partial response or reoccurrence, add an NSAID
- Change to another agent
Frovatriptan
Best Augmenting Combos for Partial Response or Treatment-Resistance
- NSAIDs or neuroleptics are often used to augment response
Frovatriptan
Tests
- None required
Adverse Effects (AEs)
Frovatriptan
How Drug Causes AEs
- Direct effect on serotonin receptors
Frovatriptan
Notable AEs
- Tingling, flushing, dizziness, palpitations, muscle pain, sensation of burning, vertigo, sensation of pressure, nausea
Frovatriptan
Life-Threatening or Dangerous AEs
- Rare cardiac events including acute MI, cardiac arrhythmias, and coronary artery vasospasm have been reported with frovatriptan
Frovatriptan
Weight Gain
- Unusual
Frovatriptan
Sedation
- Unusual
Frovatriptan
What to Do About AEs
- In most cases, only reassurance is needed. Lower dose, change to another triptan or use an alternative headache treatment
Frovatriptan
Best Augmenting Agents for AEs
Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree
